Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

This study has been completed.
Information provided by:
Fred Hutchinson Cancer Research Center Identifier:
First received: January 7, 2005
Last updated: May 5, 2010
Last verified: May 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Estimated Primary Completion Date: No date given